The Business Times
business-time-50

亚洲生物科技的“高光时刻”：从区域优势迈向全球影响力

政策改革、新模式和跨境平台，正使亚洲成为生物制药创新的关键驱动力

google-preferred-sourceAdd BT as a preferred source
    • 亚洲各国政府已将生物科技作为战略重点，通过推行政策和生态系统变革，减少创新全周期中的阻力。
    • 亚洲各国政府已将生物科技作为战略重点，通过推行政策和生态系统变革，减少创新全周期中的阻力。 图片来源：路透社

    Fu Wei

    Published Fri, Mar 20, 2026 · 05:00 PM

    本文由AI辅助翻译

    查看原文

    在今年于旧金山举行的JP摩根医疗保健大会（全球医疗保健行业最大的年度投资盛会）上，一个主题尤为突出：亚洲在全球生物科技领域已不再处于边缘地位，而是正走向中心。

    该地区在新药的发现、开发和惠及全球患者方面，正扮演着日益关键的角色。

    变化的不仅是创新的来源地，还有创新跨境流动的方式。亚洲正在构建一种“连接性组织”，以加快临床开发进程。这得益于该地区庞大且多样化的患者群体、更统一的监管标准、更深厚的资本池以及日益成熟的跨境合伙业务。

    此翻译对您是否有帮助？

    BiotechAsia-Pacific

    TRENDING NOW

    Ohmyhome (BVI) is the holding company of Ohmyhome Singapore and its subsidiaries, which provide real estate services in Singapore and Malaysia.

    Ohmyhome Ltd sells real estate business for token US$1 due to poor business and continued losses

    The house sits on a road just off Bishops Avenue, a north London street known as “Billionaire’s Row”.

    Buyer for England striker Harry Kane’s former mansion must pay £3.4 million after abandoning deal

    Race (left) and Rhonda Wong founded Ohmyhome in 2016.

    Real estate firm Ohmyhome’s journey over the past 10 years

    Vincent Tan, founder of Berjaya Group, has reduced his holdings in multiple companies within the group.

    Malaysian tycoon Vincent Tan’s sell-downs point to pruning rather than an exit plan

    Latest T-bills Treasury Bills Results & Interest NewsLatest SSB Singapore Savings Bonds NewsLatest COE Certificate of Entitlement News
    Latest Johor-Singapore SEZ NewsLatest BTO Build To Order & Sales of Balance NewsLatest STI Straits Times Index NewsLatest SGX Dividends, Share Price NewsLatest Bonds Market NewsLatest Singapore Stocks To Buy NewsLatest Singapore Economy News
    View More